✦ LIBER ✦

Alemtuzumab shows promise for the treatment of refractory T-cell prolymphocytic leukaemia

✍ Scribed by McNeely, Wendy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alemtuzumab: first-line treatment for T-

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Efficacy and safety of long-term (>7 yea

✍ Horatiu Olteanu; Alexandra M. Harrington; Sarah Ramirez; Steven H. Kroft; Parame 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Overview of alemtuzumab therapy for the

✍ Zinzani, Pier Luigi; Corradini, Paolo; Gallamini, Andrea; Grossi, Alberto; Lazza 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 284 KB

Reconstitution of the T-cell repertoire

✍ Mohammad Reza Rezvany; Mahmood Jeddi Tehrani; Claes Karlsson; Jeanette Lundin; H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

The Outcome of HyperCVAD Combined with A

✍ Jew Win Kuan; Kian Meng Chang; Ngee Siang Lau; Purushothaman Visalachy; Sen Mui 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 251 KB

Alemtuzumab vs ATG for T-Cell Depletion

✍ V.T. Potter; V.J. Tindell; L. Reiff-Zall; A. Ho; M. Kenyon; J. Marsh; A. Pagliuc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB